{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:27:12Z","timestamp":1772166432922,"version":"3.50.1"},"reference-count":93,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T00:00:00Z","timestamp":1768608000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":10,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005972","name":"Deutsche Krebshilfe","doi-asserted-by":"publisher","award":["70115371"],"award-info":[{"award-number":["70115371"]}],"id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005972","name":"Deutsche Krebshilfe","doi-asserted-by":"publisher","award":["70115398"],"award-info":[{"award-number":["70115398"]}],"id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005972","name":"Deutsche Krebshilfe","doi-asserted-by":"publisher","award":["70115402"],"award-info":[{"award-number":["70115402"]}],"id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017590","name":"Universit\u00e4tsklinikum Essen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100017590","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Lung cancer is one of the most common cancers in Germany, with around 56,000 new cases diagnosed in 2020. Approximately 65% are diagnosed at advanced stages, where symptoms such as fatigue, pain, dyspnea, and weight loss are prevalent. These patients often suffer from cardiovascular and pulmonary comorbidities, which interact with treatment toxicity, outcome, and increase treatment costs. Although exercise therapy is proven to alleviate cancer-related symptoms and to improve quality of life, current lung cancer treatment guidelines fail to adequately prioritize its crucial role.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      The Better symptom contRol with Exercise in pAtients wiTH advanced non-small cell lung cancer (BREATH) study is a prospective, three-arm randomized controlled trial (RCT) designed to assess the impact of exercise therapy on patients with advanced NSCLC (stage IIIB-IV) who are receiving first- or second-line systemic therapy in the palliative setting. Patients (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009104) are randomized in a 2:1:1 ratio into a control group (receiving exercise recommendations) or one of two intervention arms: endurance training and breathing exercise or combined endurance and resistance training. The intervention groups will exercise twice a week for 12 weeks. The control group participants will be randomized again in a 1:1 ratio into one of the two intervention arms after completion of the control period. The study will assess outcomes at baseline, 12 weeks, and 24 weeks. The primary outcome is improvement of aerobic capacity (VO\n                      <jats:sub>2<\/jats:sub>\n                      peak). Secondary outcomes include quality of life, fatigue, adherence to exercise, and adverse events. Patient representatives were involved in all stages of protocol development.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>The BREATH study addresses a significant gap in the current management of advanced lung cancer treatment by evaluating the impact of different exercise treatment protocols to reduce symptoms and improve clinical outcome. The study design and exercise program aim to enhance adherence and optimize patient-related outcomes. The results of the BREATH study have the potential to influence future guidelines and improve the management of patients with advanced NSCLC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>ClinicalTrials.gov NCT06374160. Registered on April 18, 2024.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13063-025-09416-2","type":"journal-article","created":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T03:46:20Z","timestamp":1768621580000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Improving aerobic capacity in patients with advanced non-small cell lung cancer: study protocol of the 3-armed randomized controlled BREATH trial"],"prefix":"10.1186","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0216-8232","authenticated-orcid":false,"given":"Nico","family":"De Lazzari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcel","family":"Wiesweg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0841-8738","authenticated-orcid":false,"given":"Miriam","family":"G\u00f6tte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2708-139X","authenticated-orcid":false,"given":"Jan","family":"Franco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raluca Ileana","family":"Mincu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9815-2402","authenticated-orcid":false,"given":"Johannes","family":"J\u00e4ger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8144-5428","authenticated-orcid":false,"given":"Eva-Maria","family":"Huessler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nils","family":"Kuklik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Stang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Totzeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8868-8329","authenticated-orcid":false,"given":"Mitra","family":"Tewes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,17]]},"reference":[{"key":"9416_CR1","unstructured":"Ronckers C, Spix C, Tr\u00fcbenbach C, Katalinic A, Christ M, Cicero A, Wienecke A. Krebs in Deutschland f\u00fcr 2019\/2020. Berlin: Robert Koch-Institut; 2023. Available from: https:\/\/www.krebsdaten.de\/Krebs\/DE\/Content\/Publikationen\/Krebs_in_Deutschland\/krebs_in_deutschland_2023.pdf?__blob=publicationFile."},{"key":"9416_CR2","unstructured":"Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft e.V., Deutsche Krebshilfe e.V., AWMF). S3-Leitlinie Pr\u00e4vention, Diagnostik, Therapie und Nachsorge des Lungenkarzinoms. Langversion 1.0. AWMF-Registernr.: 020\/007OL. Berlin: Leitlinienprogramm Onkologie; 2018. Available from: https:\/\/www.leitlinienprogramm-onkologie.de\/fileadmin\/user_upload\/Downloads\/Leitlinien\/Lungenkarzinom\/Version_1\/LL_Lungenkarzinom_Langversion_1.0.pdf."},{"issue":"1","key":"9416_CR3","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/JTO.0b013e3181c5920c","volume":"5","author":"D Morgensztern","year":"2010","unstructured":"Morgensztern D, Ng SH, Gao F, Govindan R. Trends in stage distribution for patients with non-small cell lung cancer: a national cancer database survey. J Thorac Oncol. 2010;5(1):29\u201333.","journal-title":"J Thorac Oncol"},{"issue":"1","key":"9416_CR4","doi-asserted-by":"publisher","first-page":"506","DOI":"10.21037\/tlcr.2020.03.40","volume":"10","author":"A Casal-Mouri\u00f1o","year":"2021","unstructured":"Casal-Mouri\u00f1o A, Ruano-Ravina A, Lorenzo-Gonz\u00e1lez M, Rodr\u00edguez-Mart\u00ednez \u00c1, Giraldo-Osorio A, Varela-Lema L, et al. Epidemiology of stage III lung cancer: frequency, diagnostic characteristics, and survival. Transl Lung Cancer Res. 2021;10(1):506\u201318.","journal-title":"Transl Lung Cancer Res"},{"issue":"1","key":"9416_CR5","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/S0885-3924(01)00305-0","volume":"22","author":"T Okuyama","year":"2001","unstructured":"Okuyama T, Tanaka K, Akechi T, Kugaya A, Okamura H, Nishiwaki Y, et al. Fatigue in ambulatory patients with advanced lung cancer: prevalence, correlated factors, and screening. J Pain Symptom Manage. 2001;22(1):554\u201364.","journal-title":"J Pain Symptom Manage"},{"key":"9416_CR6","doi-asserted-by":"publisher","first-page":"73","DOI":"10.2147\/LCTT.S85334","volume":"7","author":"S Carnio","year":"2016","unstructured":"Carnio S, Di Stefano RF, Novello S. Fatigue in lung cancer patients: symptom burden and management of challenges. Lung Cancer Targets Ther. 2016;7:73\u201381.","journal-title":"Lung Cancer Targets Ther"},{"issue":"3","key":"9416_CR7","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.lungcan.2003.08.030","volume":"43","author":"J Potter","year":"2004","unstructured":"Potter J, Higginson IJ. Pain experienced by lung cancer patients: a review of prevalence, causes, and pathophysiology. Lung Cancer. 2004;43(3):247\u201357.","journal-title":"Lung Cancer"},{"key":"9416_CR8","doi-asserted-by":"crossref","unstructured":"Hopwood P, Stephens RJ, British Medical Research Council Lung Cancer Working Party. Depression in patients with lung cancer: prevalence and risk factors derived from quality-of-life data. J Clin Oncol. 2000;18(4):893\u2013903.","DOI":"10.1200\/JCO.2000.18.4.893"},{"issue":"1","key":"9416_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-019-6451-1","volume":"20","author":"A Harle","year":"2020","unstructured":"Harle A, Molassiotis A, Buffin O, Burnham J, Smith J, Yorke J, et al. A cross-sectional study to determine the prevalence of cough and its impact in patients with lung cancer: a patient unmet need. BMC Cancer. 2020;20(1):1\u20138.","journal-title":"BMC Cancer"},{"issue":"4","key":"9416_CR10","first-page":"233","volume":"7","author":"C Ripamonti","year":"1999","unstructured":"Ripamonti C. Management of dyspnea in advanced cancer patients. Support Care Cancer. 1999;7(4):233\u201343.","journal-title":"Support Care Cancer"},{"issue":"6","key":"9416_CR11","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1016\/j.clnu.2013.11.013","volume":"33","author":"N Kiss","year":"2014","unstructured":"Kiss N, Isenring E, Gough K, Krishnasamy M. The prevalence of weight loss during (chemo)radiotherapy treatment for lung cancer and associated patient- and treatment-related factors. Clin Nutr. 2014;33(6):1074\u201380.","journal-title":"Clin Nutr"},{"issue":"2","key":"9416_CR12","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S0885-3924(99)00150-5","volume":"19","author":"ME Cooley","year":"2000","unstructured":"Cooley ME. Symptoms in adults with lung cancer: a systematic research review. J Pain Symptom Manage. 2000;19(2):137\u201353.","journal-title":"J Pain Symptom Manage"},{"issue":"2","key":"9416_CR13","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1089\/109662101750290191","volume":"4","author":"S Lutz","year":"2001","unstructured":"Lutz S, Norrell R, Bertucio C, Kachnic L, Johnson C, Arthur D, et al. Symptom frequency and severity in patients with metastatic or locally recurrent lung cancer: a prospective study using the Lung Cancer Symptom Scale in a community hospital. J Palliat Med. 2001;4(2):157\u201365.","journal-title":"J Palliat Med"},{"issue":"1","key":"9416_CR14","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.lungcan.2015.01.006","volume":"88","author":"J Kravchenko","year":"2015","unstructured":"Kravchenko J, Berry M, Arbeev K, Lyerly HK, Yashin A, Akushevich I. Cardiovascular comorbidities and survival of lung cancer patients: Medicare data based analysis. Lung Cancer. 2015;88(1):85\u201393.","journal-title":"Lung Cancer"},{"key":"9416_CR15","doi-asserted-by":"crossref","unstructured":"Herrero Rivera D, Nieto-Guerrero G\u00f3mez JM, Cacicedo Fern\u00e1ndez de Bobadilla J, Delgado D, Rivin del Campo E, Praena-Fern\u00e1ndez JM, et al. Cardiovascular disease and survival in non-small cell lung cancer: a multicenter prospective assessment. Clin Transl Oncol. 2019;21(9):1220\u201330.","DOI":"10.1007\/s12094-019-02047-5"},{"issue":"1","key":"9416_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41533-020-00214-8","volume":"31","author":"J Bossert","year":"2021","unstructured":"Bossert J, Ludwig M, Wronski P, Koetsenruijter J, Krug K, Villalobos M, et al. Lung cancer patients\u2019 comorbidities and attendance of German ambulatory physicians in a 5-year cross-sectional study. NPJ Prim Care Respir Med. 2021;31(1):1\u20136.","journal-title":"NPJ Prim Care Respir Med"},{"issue":"1","key":"9416_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-020-06759-8","volume":"20","author":"R Ding","year":"2020","unstructured":"Ding R, Zhu D, He P, Ma Y, Chen Z, Shi X. Comorbidity in lung cancer patients and its association with medical service cost and treatment choice in China. BMC Cancer. 2020;20(1):1\u201312.","journal-title":"BMC Cancer"},{"issue":"11","key":"9416_CR18","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1249\/MSS.0000000000002117","volume":"51","author":"AV Patel","year":"2019","unstructured":"Patel AV, Friedenreich CM, Moore SC, Hayes SC, Silver JK, Campbell KL, et al. American College of Sports Medicine roundtable report on physical activity, sedentary behavior, and cancer prevention and control. Med Sci Sports Exerc. 2019;51(11):2391\u2013407.","journal-title":"Med Sci Sports Exerc"},{"key":"9416_CR19","doi-asserted-by":"crossref","unstructured":"Pilotto S, Avancini A, Menis J, Sperduti I, Giaj Levra M, Berghmans T, Bironzo P, Brand\u00e3o M, De Ruysscher D, Edwards J, Faivre-Finn C, Girard N, Greillier L, Hendriks L, Lantuejoul S, Mauer M, Novello S, O\u2019Brien M, Reck M, Reguart N, Remon J, von der Th\u00fcsen J, Dingemans AC, Besse B, Milella M. Exercise in lung cancer, the healthcare providers\u2019 opinion (E.C.H.O.): results of the EORTC Lung Cancer Group (LCG) survey. Lung Cancer. 2022;169:94\u2013101.","DOI":"10.1016\/j.lungcan.2022.05.009"},{"issue":"1","key":"9416_CR20","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1002\/j.2040-4603.2019.tb00064.x","volume":"9","author":"JF Christensen","year":"2011","unstructured":"Christensen JF, Simonsen C, Hojman P. Exercise training in cancer control and treatment. Compr Physiol. 2011;9(1):165\u2013205.","journal-title":"Compr Physiol"},{"issue":"7","key":"9416_CR21","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1001\/jamaoncol.2016.6914","volume":"3","author":"KM Mustian","year":"2017","unstructured":"Mustian KM, Alfano CM, Heckler C, Kleckner AS, Kleckner IR, Leach CR, et al. Comparison of pharmaceutical, psychological, and exercise treatments for cancer-related fatigue: a meta-analysis. JAMA Oncol. 2017;3(7):961\u20138.","journal-title":"JAMA Oncol"},{"issue":"23","key":"9416_CR22","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1093\/jnci\/djt297","volume":"105","author":"KS Courneya","year":"2013","unstructured":"Courneya KS, McKenzie DC, Mackey JR, Gelmon K, Friedenreich CM, Yasui Y, et al. Effects of exercise dose and type during breast cancer chemotherapy: multicenter randomized trial. J Natl Cancer Inst. 2013;105(23):1821\u201332.","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"9416_CR23","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1002\/pon.4655","volume":"27","author":"JC Brown","year":"2018","unstructured":"Brown JC, Damjanov N, Courneya KS, Troxel AB, Zemel BS, Rickels MR, et al. A randomized dose-response trial of aerobic exercise and health-related quality of life in colon cancer survivors. Psychooncology. 2018;27(4):1221\u20138.","journal-title":"Psychooncology"},{"issue":"4","key":"9416_CR24","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1177\/1534735418807555","volume":"17","author":"J Nakano","year":"2018","unstructured":"Nakano J, Hashizume K, Fukushima T, Ueno K, Matsuura E, Ikio Y, et al. Effects of aerobic and resistance exercises on physical symptoms in cancer patients: a meta-analysis. Integr Cancer Ther. 2018;17(4):1048\u201358.","journal-title":"Integr Cancer Ther"},{"issue":"22","key":"9416_CR25","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1200\/JCO.2017.77.5809","volume":"36","author":"JM Scott","year":"2018","unstructured":"Scott JM, Zabor EC, Schwitzer E, Koelwyn GJ, Adams SC, Nilsen TS, et al. Efficacy of exercise therapy on cardiorespiratory fitness in patients with cancer: a systematic review and meta-analysis. J Clin Oncol. 2018;36(22):2297\u2013305.","journal-title":"J Clin Oncol"},{"issue":"11","key":"9416_CR26","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1249\/MSS.0b013e31829a3b63","volume":"45","author":"B Strasser","year":"2013","unstructured":"Strasser B, Steindorf K, Wiskemann J, Ulrich CM. Impact of resistance training in cancer survivors: a meta-analysis. Med Sci Sports Exerc. 2013;45(11):2080\u201390.","journal-title":"Med Sci Sports Exerc"},{"issue":"5","key":"9416_CR27","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1007\/s00198-012-2143-2","volume":"24","author":"KM Winters-Stone","year":"2013","unstructured":"Winters-Stone KM, Dobek J, Nail LM, Bennett JA, Leo MC, Torgrimson-Ojerio B, et al. Impact+ resistance training improves bone health and body composition in prematurely menopausal breast cancer survivors: a randomized controlled trial. Osteoporos Int. 2013;24(5):1637\u201346.","journal-title":"Osteoporos Int"},{"issue":"28","key":"9416_CR28","doi-asserted-by":"publisher","first-page":"4396","DOI":"10.1200\/JCO.2006.08.2024","volume":"25","author":"KS Courneya","year":"2007","unstructured":"Courneya KS, Segal RJ, Mackey JR, Gelmon K, Reid RD, Friedenreich CM, et al. Effects of aerobic and resistance exercise in breast cancer patients receiving adjuvant chemotherapy: a multicenter randomized controlled trial. J Clin Oncol. 2007;25(28):4396\u2013404.","journal-title":"J Clin Oncol"},{"key":"9416_CR29","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.2147\/OTT.S97864","volume":"9","author":"G Zhu","year":"2016","unstructured":"Zhu G, Zhang X, Wang Y, Xiong H, Zhao Y, Sun F. Effects of exercise intervention in breast cancer survivors: a meta-analysis of 33 randomized controlled trails. Onco Targets Ther. 2016;9:2153\u201362.","journal-title":"Onco Targets Ther"},{"issue":"7","key":"9416_CR30","first-page":"732","volume":"14","author":"KM Mustian","year":"2006","unstructured":"Mustian KM, Griggs JJ, Morrow GR, McTiernan A, Roscoe JA, Bole CW, et al. Exercise and side effects among 749 patients during and after treatment for cancer: a University of Rochester Cancer Center Community Clinical Oncology Program Study. Support Care Cancer. 2006;14(7):732\u201341.","journal-title":"Support Care Cancer"},{"issue":"10","key":"9416_CR31","first-page":"331","volume":"121","author":"FT Baumann","year":"2024","unstructured":"Baumann FT, Jensen W, Berling-Ernst A, Theurich S, Leitzmann M, G\u00f6tte M. Exercise therapy in oncology\u2014the impact on quality of life and side effects. Dtsch Arztebl Int. 2024;121(10):331\u20137.","journal-title":"Dtsch Arztebl Int"},{"key":"9416_CR32","doi-asserted-by":"publisher","unstructured":"Anderson L, Oldridge N, Thompson DR, Zwisler AD, Rees K, Martin N, Taylor RS. Exercise-based cardiac rehabilitation for coronary heart disease: Cochrane systematic review and meta-analysis. J Am Coll Cardiol. 2016;67(1):1\u201312. https:\/\/doi.org\/10.1016\/j.jacc.2015.10.044.","DOI":"10.1016\/j.jacc.2015.10.044"},{"issue":"4","key":"9416_CR33","first-page":"229","volume":"10","author":"HS Buttar","year":"2005","unstructured":"Buttar HS, Li T, Ravi N. Prevention of cardiovascular diseases: role of exercise, dietary interventions, obesity and smoking cessation. Exp Clin Cardiol. 2005;10(4):229\u201349.","journal-title":"Exp Clin Cardiol"},{"issue":"8","key":"9416_CR34","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1097\/PHM.0000000000000667","volume":"96","author":"M Paneroni","year":"2017","unstructured":"Paneroni M, Simonelli C, Vitacca M, Ambrosino N. Aerobic exercise training in very severe chronic obstructive pulmonary disease: a systematic review and meta-analysis. Am J Phys Med Rehabil. 2017;96(8):541\u20138.","journal-title":"Am J Phys Med Rehabil"},{"issue":"8","key":"9416_CR35","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1093\/annonc\/mdn064","volume":"19","author":"W Jacot","year":"2008","unstructured":"Jacot W, Colinet B, Bertrand D, Lacombe S, Bozonnat MC, Daur\u00e8s JP, et al. Quality of life and comorbidity score as prognostic determinants in non-small-cell lung cancer patients. Ann Oncol. 2008;19(8):1458\u201364.","journal-title":"Ann Oncol"},{"issue":"7","key":"9416_CR36","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1080\/0284186X.2017.1324213","volume":"56","author":"J Nilsson","year":"2017","unstructured":"Nilsson J, Berglund A, Bergstr\u00f6m S, Bergqvist M, Lambe M. The role of comorbidity in the management and prognosis in nonsmall cell lung cancer: a population-based study. Acta Oncol. 2017;56(7):949\u201356.","journal-title":"Acta Oncol"},{"issue":"2","key":"9416_CR37","first-page":"182","volume":"1","author":"KR Chitturi","year":"2019","unstructured":"Chitturi KR, Xu J, Araujo-Gutierrez R, Bhimaraj A, Guha A, Hussain I, et al. Immune checkpoint inhibitor-related adverse cardiovascular events in patients with lung cancer. Cardio Oncol. 2019;1(2):182\u201392.","journal-title":"Cardio Oncol"},{"issue":"6","key":"9416_CR38","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1177\/0269216309105400","volume":"23","author":"AT Johnsen","year":"2009","unstructured":"Johnsen AT, Petersen MA, Pedersen L, Groenvold M. Symptoms and problems in a nationally representative sample of advanced cancer patients. Palliat Med. 2009;23(6):491\u2013501.","journal-title":"Palliat Med"},{"issue":"17","key":"9416_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13174478","volume":"13","author":"N De Lazzari","year":"2021","unstructured":"De Lazzari N, Niels T, Tewes M, G\u00f6tte M. A systematic review of the safety, feasibility and benefits of exercise for patients with advanced cancer. Cancers (Basel). 2021;13(17):4478.","journal-title":"Cancers (Basel)"},{"issue":"12","key":"9416_CR40","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.1016\/j.apmr.2018.04.008","volume":"99","author":"R Heywood","year":"2018","unstructured":"Heywood R, McCarthy AL, Skinner TL. Efficacy of exercise interventions in patients with advanced cancer: a systematic review. Arch Phys Med Rehabil. 2018;99(12):2595\u2013620.","journal-title":"Arch Phys Med Rehabil"},{"key":"9416_CR41","doi-asserted-by":"publisher","unstructured":"Toohey K, Chapman M, Rushby AM, Urban K, Ingham G, Singh B. The effects of physical exercise in the palliative care phase for people with advanced cancer: a systematic review with meta-analysis. J Cancer Surviv. 2023;17(2):399\u2013415. https:\/\/doi.org\/10.1007\/s11764-021-01153-0.","DOI":"10.1007\/s11764-021-01153-0"},{"issue":"8","key":"9416_CR42","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1093\/annonc\/mdx205","volume":"28","author":"HM Dhillon","year":"2017","unstructured":"Dhillon HM, Bell ML, van der Ploeg HP, Turner JD, Kabourakis M, Spencer L, et al. Impact of physical activity on fatigue and quality of life in people with advanced lung cancer: a randomized controlled trial. Ann Oncol. 2017;28(8):1889\u201397.","journal-title":"Ann Oncol"},{"issue":"4","key":"9416_CR43","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/j.clnu.2017.05.027","volume":"37","author":"A Uster","year":"2018","unstructured":"Uster A, Ruehlin M, Mey S, Gisi D, Knols R, Imoberdorf R, et al. Effects of nutrition and physical exercise intervention in palliative cancer patients: a randomized controlled trial. Clin Nutr. 2018;37(4):1202\u20139.","journal-title":"Clin Nutr"},{"issue":"12","key":"9416_CR44","first-page":"3169","volume":"20","author":"CL Hwang","year":"2012","unstructured":"Hwang CL, Yu CJ, Shih JY, Yang PC, Wu YT. Effects of exercise training on exercise capacity in patients with non-small cell lung cancer receiving targeted therapy. Support Care Cancer. 2012;20(12):3169\u201377.","journal-title":"Support Care Cancer"},{"issue":"2","key":"9416_CR45","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.lungcan.2011.07.006","volume":"75","author":"M Quist","year":"2012","unstructured":"Quist M, R\u00f8rth M, Langer S, Jones LW, Laursen JH, Pappot H, et al. Safety and feasibility of a combined exercise intervention for inoperable lung cancer patients undergoing chemotherapy: a pilot study. Lung Cancer. 2012;75(2):203\u20138.","journal-title":"Lung Cancer"},{"issue":"8","key":"9416_CR46","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1200\/JCO.2016.70.5046","volume":"35","author":"JS Temel","year":"2017","unstructured":"Temel JS, Greer JA, El-Jawahri A, Pirl WF, Park ER, Jackson VA, et al. Effects of early integrated palliative care in patients with lung and GI cancer: a randomized clinical trial. J Clin Oncol. 2017;35(8):834\u201341.","journal-title":"J Clin Oncol"},{"key":"9416_CR47","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.lungcan.2020.05.003","volume":"145","author":"M Quist","year":"2020","unstructured":"Quist M, Langer SW, Lillelund C, Winther L, Laursen JH, Christensen KB, et al. Effects of an exercise intervention for patients with advanced inoperable lung cancer undergoing chemotherapy: a randomized clinical trial. Lung Cancer. 2020;145:76\u201382.","journal-title":"Lung Cancer"},{"issue":"2","key":"9416_CR48","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1097\/HCR.0000000000000410","volume":"39","author":"A Rutkowska","year":"2019","unstructured":"Rutkowska A, Jastrzebski D, Rutkowski S, \u017bebrowska A, Stanula A, Szczegielniak J, et al. Exercise training in patients with non-small cell lung cancer during in-hospital chemotherapy treatment: a randomized controlled trial. J Cardiopulm Rehabil Prev. 2019;39(2):127\u201332.","journal-title":"J Cardiopulm Rehabil Prev"},{"issue":"5","key":"9416_CR49","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.jpainsymman.2012.05.006","volume":"45","author":"AL Cheville","year":"2013","unstructured":"Cheville AL, Kollasch J, Vandenberg J, Shen T, Grothey A, Gamble G, et al. A home-based exercise program to improve function, fatigue, and sleep quality in patients with stage IV lung and colorectal cancer: a randomized controlled trial. J Pain Symptom Manage. 2013;45(5):811\u201321.","journal-title":"J Pain Symptom Manage"},{"issue":"1","key":"9416_CR50","first-page":"95","volume":"22","author":"CC Henke","year":"2014","unstructured":"Henke CC, Cabri J, Fricke L, Pankow W, Kandilakis G, Feyer PC, et al. Strength and endurance training in the treatment of lung cancer patients in stages IIIA\/IIIB\/IV. Support Care Cancer. 2014;22(1):95\u2013101.","journal-title":"Support Care Cancer"},{"key":"9416_CR51","doi-asserted-by":"publisher","unstructured":"Maddocks M, Halliday V, Chauhan A, Taylor V, Nelson A, Sampson C, Byrne A, Griffiths G, Wilcock A. Neuromuscular electrical stimulation of the quadriceps in patients with non-small cell lung cancer receiving palliative chemotherapy: a randomized phase II study. PLoS One. 2013;8(12):e86059. https:\/\/doi.org\/10.1371\/journal.pone.0086059.","DOI":"10.1371\/journal.pone.0086059"},{"issue":"6","key":"9416_CR52","first-page":"1637","volume":"23","author":"A Molassiotis","year":"2015","unstructured":"Molassiotis A, Charalambous A, Taylor P, Stamataki Z, Summers Y. The effect of resistance inspiratory muscle training in the management of breathlessness in patients with thoracic malignancies: a feasibility randomised trial. Support Care Cancer. 2015;23(6):1637\u201345.","journal-title":"Support Care Cancer"},{"key":"9416_CR53","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1159\/000358157","volume":"37","author":"S Hummler","year":"2014","unstructured":"Hummler S, Zoz M, Thomas M, Ulrich CM, Huber G, Wiskemann J. Pilot study on fatigue levels in patients with lung cancer: correlations with muscle strength and 6-minute walk tests. Oncol Res Treat. 2014;37:36\u201341.","journal-title":"Oncol Res Treat"},{"issue":"4","key":"9416_CR54","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1249\/MSS.0000000000000158","volume":"46","author":"L Kuehr","year":"2014","unstructured":"Kuehr L, Wiskemann J, Abel U, Ulrich CM, Hummler S, Thomas M. Exercise in patients with non-small cell lung cancer. Med Sci Sports Exerc. 2014;46(4):656\u201363.","journal-title":"Med Sci Sports Exerc"},{"key":"9416_CR55","doi-asserted-by":"crossref","unstructured":"Jastrz\u0119bski D, Maksymiak M, Kostorz S, Bezubka B, Osmanska I, M\u0142ynczak T, et al. Pulmonary rehabilitation in advanced lung cancer patients during chemotherapy. In: Respiratory health. Springer, Cham; 2018. 57\u201364.","DOI":"10.1007\/5584_2015_134"},{"issue":"1","key":"9416_CR56","first-page":"1","volume":"41","author":"MC Garassino","year":"2023","unstructured":"Garassino MC, Baas P, Berghmans T, Giaj-Levra M, Goffin JR, de Marinis F, et al. Systemic therapy for small-cell lung cancer: ASCO\u2013Ontario health (Cancer Care Ontario) living guideline. J Clin Oncol. 2023;41(1):1\u201312.","journal-title":"J Clin Oncol"},{"issue":"9","key":"9416_CR57","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1200\/JCO.20.03570","volume":"39","author":"M Reck","year":"2021","unstructured":"Reck M, Remon J, Hellmann MD, Kerr KM, Peters S, Baas P, et al. Therapy for stage IV non\u2013small-cell lung cancer with driver alterations: ASCO living guideline. J Clin Oncol. 2021;39(9):1040\u201391.","journal-title":"J Clin Oncol"},{"issue":"1","key":"9416_CR58","first-page":"33","volume":"7","author":"P Sanzgiri","year":"2019","unstructured":"Sanzgiri P, Koppikar S, Krishna BA, Patil P, Reddy C. Toxicity to immune checkpoint inhibitors presenting as pulmonary arterial vasculopathy and rapidly progressing right ventricular dysfunction. Am J Cancer Case Rep. 2019;7(1):33\u20139.","journal-title":"Am J Cancer Case Rep"},{"issue":"24","key":"9416_CR59","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1161\/CIRCULATIONAHA.120.049981","volume":"142","author":"ZD Drobni","year":"2020","unstructured":"Drobni ZD, Alvi RM, Taron J, Zafar A, Murphy SP, Rambarat PK, et al. Association between immune checkpoint inhibitors with cardiovascular events and atherosclerotic plaque. Circulation. 2020;142(24):2299\u2013311.","journal-title":"Circulation"},{"key":"9416_CR60","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2019-000261","author":"C Dolladille","year":"2020","unstructured":"Dolladille C, Ederhy S, Allouche S, Dupas Q, Gervais R, Madelaine J, et al. Late cardiac adverse events in patients with cancer treated with immune checkpoint inhibitors. J Immunother Cancer. 2020. https:\/\/doi.org\/10.1136\/jitc-2019-000261.","journal-title":"J Immunother Cancer"},{"issue":"21","key":"9416_CR61","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1161\/CIRCULATIONAHA.117.030571","volume":"136","author":"M Escudier","year":"2017","unstructured":"Escudier M, Cautela J, Malissen N, Ancedy Y, Orabona M, Pinto J, et al. Clinical features, management, and outcomes of immune checkpoint inhibitor\u2013related cardiotoxicity. Circulation. 2017;136(21):2085\u20137.","journal-title":"Circulation"},{"issue":"8","key":"9416_CR62","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1016\/j.amjcard.2019.01.013","volume":"123","author":"N Palaskas","year":"2019","unstructured":"Palaskas N, Morgan J, Daigle T, Banchs J, Durand JB, Hong D, et al. Targeted cancer therapies with pericardial effusions requiring pericardiocentesis focusing on immune checkpoint inhibitors. Am J Cardiol. 2019;123(8):1351\u20137.","journal-title":"Am J Cardiol"},{"key":"9416_CR63","doi-asserted-by":"publisher","DOI":"10.21037\/tlcr.2017.12.10","author":"YB Hu","year":"2017","unstructured":"Hu YB, Zhang Q, Li HJ, Michot JM, Liu HB, Zhan P, et al. Evaluation of rare but severe immune related adverse effects in PD-1 and PD-L1 inhibitors in non-small cell lung cancer: a meta-analysis. Transl Lung Cancer Res. 2017. https:\/\/doi.org\/10.21037\/tlcr.2017.12.10.","journal-title":"Transl Lung Cancer Res"},{"issue":"2","key":"9416_CR64","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/s00421-020-04552-w","volume":"121","author":"A Schenk","year":"2021","unstructured":"Schenk A, Joisten N, Walzik D, Koliamitra C, Schoser D, Bloch W, et al. Acute exercise impacts AhR and PD-1 levels of CD8+ T-cells\u2014exploratory results from a randomized cross-over trial comparing endurance versus resistance exercise. Eur J Appl Physiol. 2021;121(2):637\u201344.","journal-title":"Eur J Appl Physiol"},{"issue":"11","key":"9416_CR65","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21113816","volume":"21","author":"G Holmen Olofsson","year":"2020","unstructured":"Holmen Olofsson G, Jensen AWP, Idorn M. Exercise oncology and immuno-oncology; a (future) dynamic duo. Int J Mol Sci. 2020;21(11):3816.","journal-title":"Int J Mol Sci"},{"key":"9416_CR66","first-page":"130","volume":"26","author":"A Mart\u00edn-Ruiz","year":"2020","unstructured":"Mart\u00edn-Ruiz A, Fiuza-Luces C, Rinc\u00f3n-Castanedo C, Fern\u00e1ndez-Moreno D, G\u00e1lvez BG, Mart\u00ednez-Mart\u00ednez E, et al. Benefits of exercise and immunotherapy in a murine model of human non-small-cell lung carcinoma. Exerc Immunol Rev. 2020;26:130\u201341.","journal-title":"Exerc Immunol Rev"},{"issue":"24","key":"9416_CR67","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13246364","volume":"13","author":"AL Shaver","year":"2021","unstructured":"Shaver AL, Sharma S, Nikita N, Lefler DS, Basu-Mallick A, Johnson JM, et al. The effects of physical activity on cancer patients undergoing treatment with immune checkpoint inhibitors: a scoping review. Cancers (Basel). 2021;13(24):6364.","journal-title":"Cancers (Basel)"},{"issue":"8","key":"9416_CR68","first-page":"826","volume":"28","author":"A Cohen-Solal","year":"2021","unstructured":"Cohen-Solal A. Exercise to prevent cardiotoxicity in cancer: ready for implementation? Eur J Prev Cardiol. 2021;28(8):826\u20139.","journal-title":"Eur J Prev Cardiol"},{"key":"9416_CR69","doi-asserted-by":"publisher","DOI":"10.2307\/2529712","author":"SJ Pocock","year":"1975","unstructured":"Pocock SJ, Simon R. Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics. 1975. https:\/\/doi.org\/10.2307\/2529712.","journal-title":"Biometrics"},{"issue":"2","key":"9416_CR70","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.lungcan.2006.10.006","volume":"55","author":"LW Jones","year":"2007","unstructured":"Jones LW, Eves ND, Mackey JR, Peddle CJ, Haykowsky M, Joy AA, et al. Safety and feasibility of cardiopulmonary exercise testing in patients with advanced cancer. Lung Cancer. 2007;55(2):225\u201332.","journal-title":"Lung Cancer"},{"issue":"1","key":"9416_CR71","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1080\/07303084.1993.10606684","volume":"64","author":"M Brzycki","year":"1993","unstructured":"Brzycki M. Strength testing\u2014predicting a one-rep max from reps-to-fatigue. J Phys Educ Recreat Dance. 1993;64(1):88\u201390.","journal-title":"J Phys Educ Recreat Dance"},{"issue":"2","key":"9416_CR72","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0885-3924(96)00274-6","volume":"13","author":"SB Yellen","year":"1997","unstructured":"Yellen SB, Cella DF, Webster K, Blendowski C, Kaplan E. Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J Pain Symptom Manage. 1997;13(2):63\u201374.","journal-title":"J Pain Symptom Manage"},{"issue":"1","key":"9416_CR73","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jpsychores.2012.10.011","volume":"74","author":"Z Butt","year":"2013","unstructured":"Butt Z, Lai JS, Rao D, Heinemann AW, Bill A, Cella D. Measurement of fatigue in cancer, stroke, and HIV using the functional assessment of chronic illness therapy\u2014fatigue (FACIT-F) scale. J Psychosom Res. 2013;74(1):64\u20138.","journal-title":"J Psychosom Res"},{"issue":"11","key":"9416_CR74","doi-asserted-by":"publisher","first-page":"2874","DOI":"10.1093\/annonc\/mdx453","volume":"28","author":"M Koller","year":"2017","unstructured":"Koller M, Hjermstad MJ, Tomaszewski KA, Tomaszewska IM, Hornslien K, Harle A, et al. An international study to revise the EORTC questionnaire for assessing quality of life in lung cancer patients. Ann Oncol. 2017;28(11):2874\u201381.","journal-title":"Ann Oncol"},{"key":"9416_CR75","first-page":"47","volume":"170","author":"M Koller","year":"2022","unstructured":"Koller M, Musoro JZ, Tomaszewski K, Coens C, King MT, Sprangers MA, et al. Minimally important differences of EORTC QLQ-C30 scales in patients with lung cancer or malignant pleural mesothelioma\u2013interpretation guidance derived from two randomized EORTC trials. Lung Cancer. 2022;170:47\u201353.","journal-title":"Lung Cancer"},{"key":"9416_CR76","doi-asserted-by":"publisher","unstructured":"Guest G, Fleming P. Mixed methods research. In: Guest G, Namey E, editors. Public health research methods. Thousand Oaks (CA): SAGE Publications; 2015. p. 1\u201323. https:\/\/doi.org\/10.4135\/9781483398839.n19.","DOI":"10.4135\/9781483398839.n19"},{"key":"9416_CR77","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-531-93267-5","volume-title":"Mixed methods: Methodologie, Forschungsdesigns und Analyseverfahren","author":"U Kuckartz","year":"2014","unstructured":"Kuckartz U. Mixed methods: Methodologie, Forschungsdesigns und Analyseverfahren. Heidelberg: Springer-Verlag; 2014."},{"key":"9416_CR78","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/978-94-017-9181-6_13","volume-title":"Approaches to qualitative research in mathematics education: examples of methodology and methods","author":"P Mayring","year":"2015","unstructured":"Mayring P. Qualitative content analysis: theoretical background and procedures. In: Bikner-Ahsbahs A, Knipping C, Presmeg N, editors. Approaches to qualitative research in mathematics education: examples of methodology and methods. Dordrecht: Springer; 2015. p. 365\u201380."},{"key":"9416_CR79","volume-title":"Designing and conducting mixed methods research","author":"JW Creswell","year":"2017","unstructured":"Creswell JW, Plano Clark VL. Designing and conducting mixed methods research. 3rd ed. Thousand Oaks, CA: Sage Publications; 2017.","edition":"3rd ed"},{"key":"9416_CR80","volume-title":"An introduction to qualitative research","author":"U Flick","year":"2018","unstructured":"Flick U. An introduction to qualitative research. Los Angeles: SAGE Publications; 2018."},{"key":"9416_CR81","doi-asserted-by":"publisher","unstructured":"Quist M, Langer SW, Lillelund C, Winther L, Laursen JH, Christensen KB, R\u00f8rth M, Adamsen L. Effects of an exercise intervention for patients with advanced inoperable lung cancer undergoing chemotherapy: a randomized clinical trial. Lung Cancer. 2020;145:76\u201382. https:\/\/doi.org\/10.1016\/j.lungcan.2020.05.003.","DOI":"10.1016\/j.lungcan.2020.05.003"},{"issue":"1","key":"9416_CR82","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-020-06738-z","volume":"20","author":"F Hardtstock","year":"2020","unstructured":"Hardtstock F, Myers D, Li T, Cizova D, Maywald U, Wilke T, et al. Real-world treatment and survival of patients with advanced non-small cell lung cancer: a German retrospective data analysis. BMC Cancer. 2020;20(1):1\u201314.","journal-title":"BMC Cancer"},{"issue":"9","key":"9416_CR83","doi-asserted-by":"publisher","first-page":"2943","DOI":"10.1093\/bioinformatics\/btaa022","volume":"36","author":"F Madrid-Gambin","year":"2020","unstructured":"Madrid-Gambin F, Oller-Moreno S, Fernandez L, Bartova S, Giner MP, Joyce C, et al. AlpsNMR: an R package for signal processing of fully untargeted NMR-based metabolomics. Bioinformatics. 2020;36(9):2943\u20135.","journal-title":"Bioinformatics"},{"key":"9416_CR84","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.ypmed.2017.07.015","volume":"104","author":"KL Dittus","year":"2017","unstructured":"Dittus KL, Gramling RE, Ades PA. Exercise interventions for individuals with advanced cancer: a systematic review. Prev Med. 2017;104:124\u201332.","journal-title":"Prev Med"},{"issue":"2","key":"9416_CR85","doi-asserted-by":"publisher","DOI":"10.1016\/j.soncn.2020.151076","volume":"36","author":"B Singh","year":"2020","unstructured":"Singh B, Spence R, Steele ML, Sandler CX, Peake JM, Hayes SC. Exercise for individuals with lung cancer: a systematic review and meta-analysis of adverse events, feasibility, and effectiveness. Semin Oncol Nurs. 2020;36(2):151076.","journal-title":"Semin Oncol Nurs"},{"key":"9416_CR86","doi-asserted-by":"crossref","unstructured":"Brindley Hapuarachi, Danson S, Wadsley J, Muthana M. Exercise to transform tumours from cold to hot and improve immunotherapy responsiveness. Front Immunol. 2023;14:849502.","DOI":"10.3389\/fimmu.2023.1335256"},{"key":"9416_CR87","doi-asserted-by":"publisher","unstructured":"Gustafson MP, Wheatley-Guy CM, Rosenthal AC, Gastineau DA, Katsanis E, Johnson BD, Simpson RJ. Exercise and the immune system: taking steps to improve responses to cancer immunotherapy. J Immunother Cancer. 2021;9(7):e001872. https:\/\/doi.org\/10.1136\/jitc-2020-001872.","DOI":"10.1136\/jitc-2020-001872"},{"key":"9416_CR88","unstructured":"Dieli-Conwright C, Dana-Farber Cancer Institute. Feasibility and preliminary efficacy of exercise during immunotherapy in patients with lung cancer: the INHALE trial. ClinicalTrials.gov. 2024 [cited 2024 Apr 15]. Available from: https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT06026111"},{"key":"9416_CR89","unstructured":"National Cancer Institute (NCI). The Effect of Diet and Exercise on ImmuNotherapy and the Microbiome (EDEN). ClinicalTrials.gov. 2024 [cited 2024 Apr 15]. Available from: https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT04866810"},{"key":"9416_CR90","unstructured":"Peat N, Guy\u2019s and St Thomas\u2019 NHS Foundation Trust. Physical activity and exercise in urological cancers receiving immune check point inhibitor treatment - a qualitative study exploring patient perspectives and experiences. ClinicalTrials.gov. 2023 [cited 2024 Apr 15]. Available from: https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT06152926"},{"key":"9416_CR91","unstructured":"M.D. Anderson Cancer Center, National Cancer Institute (NCI). Diet and Immune Effects Trial: DIET- a randomized double blinded dietary intervention study in patients with metastatic melanoma receiving immunotherapy. ClinicalTrials.gov. 2023 [cited 2024 Apr 15]. Available from: https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT04645680"},{"key":"9416_CR92","unstructured":"Straten P thor, Herlev Hospital. High intensity aerobic exercise training and immune cell mobilization in patients with lung cancer (HI AIM). ClinicalTrials.gov. 2024 [cited 2024 Apr 15]. Available from: https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT04263467"},{"key":"9416_CR93","doi-asserted-by":"publisher","unstructured":"Gouez M, P\u00e9rol O, P\u00e9rol M, Caux C, M\u00e9n\u00e9trier-Caux C, Villard M, Walzer T, Delrieu L, Saintigny P, Marijnen P, Pialoux V, Fervers B. Effect of acute aerobic exercise before immunotherapy and chemotherapy infusion in patients with metastatic non-small-cell lung cancer: protocol for the ERICA feasibility trial. BMJ Open. 2022;12(4):e056819. https:\/\/doi.org\/10.1136\/bmjopen-2021-056819.","DOI":"10.1136\/bmjopen-2021-056819"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-025-09416-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-025-09416-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-025-09416-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T14:02:55Z","timestamp":1769522575000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13063-025-09416-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,17]]},"references-count":93,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9416"],"URL":"https:\/\/doi.org\/10.1186\/s13063-025-09416-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7271256\/v1","asserted-by":"object"}]},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,17]]},"assertion":[{"value":"1 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval for the study was obtained from the Ethics Committee of the Medical Faculty University of Duisburg-Essen under the following number: 22-10522-BO.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests within the BREATH study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"88"}}